COVID-19: Developing Drugs and Biological Products for Treatment or Prevention Guidance for Industry
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) May 2020 Clinical/Medical